VANCOUVER, June 6, 2011 /CNW/ - The recently formed Patient Safety and
Quality Assurance Section of the Canadian Association of Pathologists
(CAP-ACP) today released guidelines on investigations by health
administrators into allegations of irregularities in laboratories.
"These guidelines will ensure fairness and transparency, and that
measures can be taken to prevent a recurrence," says Dr. Diponkar
Banerjee, section chair.
The new section has been formed to consolidate the organization's
activities on patient safety and quality assurance. It includes
Canadian Immunohistochemistry Quality Control, a body that offers
laboratories the opportunity to confirm the accuracy of tests such as
hormone receptors used in patients with breast cancer.
It also includes the National Standards Committee on High Complexity
Laboratory Testing, which has issued guidelines on complex tests such
as breast cancer hormone receptor tests, and continues to develop
guidelines on other complex tests used in important treatment decisions
for patients with cancer and other diseases.
The section organizes education sessions for pathologists on quality in
laboratories and does research into the quality of laboratory work with
a view to developing guidelines.
Members of the CAP-ACP are attending the Canadian Laboratory Medicine Congress, jointly organized by the Canadian Association of Pathologists and the
Canadian Society of Clinical Chemists. The congress is taking place at
the Fairmont Hotel Vancouver June 4 - 8.
SOURCE Canadian Association of Pathologists
For further information:
Association Manager, Canadian Association of Pathologists